Estimated reading time: 6 minutes Key Takeaways Accurate economic data drives smarter monetary policy and stronger markets. Common pitfalls include measurement errors and statistical bias. Modern solutions blend traditional validation …
Latest in Trading News
-
-
Estimated reading time: 4 minutes Key Takeaways Amazon’s *bold* push into grocery delivery has lifted its share price to fresh highs. Plans to expand Amazon Fresh to 2,300+ cities by …
-
Estimated reading time: 6 minutes Key Takeaways Consumer sentiment is rising even as hard economic indicators soften. Traditional recession models that lean on confidence surveys may misfire. Analysts now blend …
-
Estimated reading time: 4 minutes Key Takeaways The Dow closed at 44,922.27, only 0.4 % below its record high. Twenty-four of thirty constituents advanced, led by industrials and financials. Investors grew optimistic on …
-
Estimated reading time: 6 minutes Key Takeaways Fed cuts have not translated into cheaper home loans, with the average 30-year fixed mortgage still hovering near 7 percent. Long-term yields, particularly ten-year …
-
Estimated reading time: 4 minutes Key Takeaways Dow Jones surged 463.66 points to 44,922.27, sitting just 0.4 % below its all-time high. Broad-based gains saw 10 of 11 S&P 500 sectors finish higher. …
-
Estimated reading time: 4 minutes Key Takeaways The Dow Jones Industrial Average ended 1% higher, sitting just below its all-time high. Rotation into blue chips highlights a preference for balance-sheet …
-
Estimated reading time: 5 minutes Key Takeaways Strategists project the S&P 500 to climb toward 7,500 by 2026, with interim milestones of 7,000–7,100 in 2025. Forecasts hinge on steady earnings growth, …
-
Estimated reading time: 4 minutes Key Takeaways The Dow Jones Industrial Average edged within 60 points of the 45,000 milestone amid sturdy market breadth. *Tech* and *bank* stocks provided the …
-
Estimated reading time: 6 minutes Key Takeaways Volatility surged as traders reacted to mixed macro data and sector-specific headlines. Mainz Biomed NV (MYNZ) rallied more than 17% on optimism around its biomedical pipeline. …